WAVE LIFE SCIENCES LTD. Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31)
WAVE LIFE SCIENCES LTD. (WVE) reported Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) of -$352.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-02.
Discontinued › Notes
us-gaap:CumulativeEffectOnRetainedEarningsNetOfTax1 · last filed 2020-03-02
- WAVE LIFE SCIENCES LTD. cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2018-03-31 was -$352.00K.
- WAVE LIFE SCIENCES LTD. cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for fiscal 2018 was -$352.00K.
| Period end | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 3 month | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 12 month |
|---|---|---|
| 2018-12-31 | -$352.00K 10-K · filed 2020-03-02 | |
| 2018-03-31 | -$352.00K 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |